-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Talis Biomedical Corp quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2020 to Q2 2024.
- Talis Biomedical Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $791K, a 26.5% decline year-over-year.
- Talis Biomedical Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $3.48M, a 28% decline year-over-year.
- Talis Biomedical Corp annual Share-based Payment Arrangement, Expense for 2023 was $4.35M, a 18.9% decline from 2022.
- Talis Biomedical Corp annual Share-based Payment Arrangement, Expense for 2022 was $5.37M, a 41.7% decline from 2021.
- Talis Biomedical Corp annual Share-based Payment Arrangement, Expense for 2021 was $9.21M, a 150% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)